Webinar: Challenges in Antiviral Therapy for Hepatitis C

When:  Jul 23, 2019 from 1:00 PM to 2:00 PM (ET)
2019-07227-Challenges_in_Antiviral_Therapy_Webinar_Graphics-560x250.jpgManagement of HCV after therapy has complexity if patients continue to engage in high risk activities, are at risk for advanced liver disease progression or have failed first line therapy. In addition, these complexities are especially important to consider as HCV therapy moves outside of subspecialty care.

Stuart Gordon, MD, FAASLD
Joseph Lim, MD, FAASLD
Brian Pearlman, MD

Nancy Reau, MD, FAASLD